iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
2B70ETF€8.11+2.14%Today
24h Range
€7.93€8.15
Market Overview
Total Assets€522.30M
Expense Ratio0.35%
52W High€8.15
52W Low€5.18
Technicals
50-Day MA€7.41
200-Day MA€7.09
Risk Metrics
1Y Volatility13.22%
3Y Volatility16.13%
Sharpe Ratio (3Y)0.61
Portfolio Allocation
US Stock94.1%
Non-US Stock5.7%
Cash0.2%
Recently Happened
Loading...
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
2B70ETF€8.11+2.14%Today
24h Range
€7.93€8.15
Market Overview
Total Assets€522.30M
Expense Ratio0.35%
52W High€8.15
52W Low€5.18
Technicals
50-Day MA€7.41
200-Day MA€7.09
Risk Metrics
1Y Volatility13.22%
3Y Volatility16.13%
Sharpe Ratio (3Y)0.61
Portfolio Allocation
US Stock94.1%
Non-US Stock5.7%
Cash0.2%
Recently Happened
Loading...
Performance
YTD
+4.57%
1Y
+38.83%
3Y
+13.07%
5Y
+3.66%
Portfolio Allocation
US Stock94.1%
Non-US Stock5.7%
Cash0.2%
Top 10 Holdings
10 holdings total1Gilead Sciences Inc
7.38%GILD
2Vertex Pharmaceuticals Inc
7.36%VRTX
3Amgen Inc
7.09%AMGN
4Regeneron Pharmaceuticals Inc
5.07%REGN
5Alnylam Pharmaceuticals Inc
3.18%ALNY
6Revolution Medicines Inc
2.48%RVMD
7Biogen Inc
2.28%BIIB
8Illumina Inc
1.98%ILMN
9United Therapeutics Corporation
1.94%UTHR
10Royalty Pharma Plc
1.90%RPRX
Top 10 Total40.67%
| # | Name | Ticker | Weight |
|---|---|---|---|
| 1 | Gilead Sciences Inc | GILD | 7.38% |
| 2 | Vertex Pharmaceuticals Inc | VRTX | 7.36% |
| 3 | Amgen Inc | AMGN | 7.09% |
| 4 | Regeneron Pharmaceuticals Inc | REGN | 5.07% |
| 5 | Alnylam Pharmaceuticals Inc | ALNY | 3.18% |
| 6 | Revolution Medicines Inc | RVMD | 2.48% |
| 7 | Biogen Inc | BIIB | 2.28% |
| 8 | Illumina Inc | ILMN | 1.98% |
| 9 | United Therapeutics Corporation | UTHR | 1.94% |
| 10 | Royalty Pharma Plc | RPRX | 1.90% |
| Top 10 Total | 40.67% | ||
Performance
YTD
+4.57%
1Y
+38.83%
3Y
+13.07%
5Y
+3.66%
Portfolio Allocation
US Stock94.1%
Non-US Stock5.7%
Cash0.2%
Top 10 Holdings
10 holdings total1Gilead Sciences Inc
7.38%GILD
2Vertex Pharmaceuticals Inc
7.36%VRTX
3Amgen Inc
7.09%AMGN
4Regeneron Pharmaceuticals Inc
5.07%REGN
5Alnylam Pharmaceuticals Inc
3.18%ALNY
6Revolution Medicines Inc
2.48%RVMD
7Biogen Inc
2.28%BIIB
8Illumina Inc
1.98%ILMN
9United Therapeutics Corporation
1.94%UTHR
10Royalty Pharma Plc
1.90%RPRX
Top 10 Total40.67%
| # | Name | Ticker | Weight |
|---|---|---|---|
| 1 | Gilead Sciences Inc | GILD | 7.38% |
| 2 | Vertex Pharmaceuticals Inc | VRTX | 7.36% |
| 3 | Amgen Inc | AMGN | 7.09% |
| 4 | Regeneron Pharmaceuticals Inc | REGN | 5.07% |
| 5 | Alnylam Pharmaceuticals Inc | ALNY | 3.18% |
| 6 | Revolution Medicines Inc | RVMD | 2.48% |
| 7 | Biogen Inc | BIIB | 2.28% |
| 8 | Illumina Inc | ILMN | 1.98% |
| 9 | United Therapeutics Corporation | UTHR | 1.94% |
| 10 | Royalty Pharma Plc | RPRX | 1.90% |
| Top 10 Total | 40.67% | ||
Technical Analysis
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap.
Trade iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)